| Nov 15 |
Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
|
| Sep 4 |
Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 9 |
Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024
|
| Jul 31 |
Cencora (COR) Surpasses Q3 Earnings and Revenue Estimates
|
| Jul 25 |
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024
|
| Jul 9 |
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial
|
| Jul 1 |
Sera Prognostics joins Russell 2000, Russell 3000 indexes
|
| Jul 1 |
SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION
|
| Jun 20 |
Sera Prognostics, Inc. (NASDAQ:SERA) most popular amongst individual investors who own 31% of the shares, institutions hold 29%
|
